Miss Rosie Mundy
Teams and roles for Rosie Mundy
Research Associate
Research student
Publication
2025
- Lovatt, C. et al. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23 (10), pp.3319-3326. (10.1016/j.jtha.2025.06.006)
2023
- Mundy, R. M. et al. 2023. Broad sialic acid usage amongst species D human adenovirus. npj Viruses 1 1. (10.1038/s44298-023-00001-5)
2022
- Bates, E. A. et al. 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp.43-56. (10.1016/j.omto.2022.03.007)
2019
- Baker, A. et al. 2019. Human adenovirus type 26 uses sialic acid - bearing glycans as a primary cell entry receptor. Science Advances 5 (9) eaax3567. (10.1126/sciadv.aax3567)
Articles
- Baker, A. et al. 2019. Human adenovirus type 26 uses sialic acid - bearing glycans as a primary cell entry receptor. Science Advances 5 (9) eaax3567. (10.1126/sciadv.aax3567)
- Bates, E. A. et al. 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp.43-56. (10.1016/j.omto.2022.03.007)
- Lovatt, C. et al. 2025. Investigating endothelial cell transduction and hexon: platelet factor 4 binding of ChAdOx1 in the context of vaccine-induced thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis 23 (10), pp.3319-3326. (10.1016/j.jtha.2025.06.006)
- Mundy, R. M. et al. 2023. Broad sialic acid usage amongst species D human adenovirus. npj Viruses 1 1. (10.1038/s44298-023-00001-5)